#529 on the rich list of 14,452 insiders
P. Roy Vagelos
Director at Regeneron Pharmaceuticals. Based in Tarrytown, New York.
$431M
in disclosed stock, −$10.4M (−2.35%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 529th of 14,452
- Companies held
- 1
- Largest holding
- REGN, 100.0% of total
- Latest SEC filing
- Apr 3, 2023
What the $431M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN Common Stock | Directly | 312,578 | $923.34 | $289M | 66.9% | Form 4, Apr 3, 2023 |
| Regeneron Pharmaceuticals REGN Common Stock | Through CLAT | 125,493 | $923.34 | $116M | 26.9% | Form 4, Apr 3, 2023 |
| Regeneron Pharmaceuticals REGN Common Stock | Through trust for grandch | 23,461 | $923.34 | $21.7M | 5.0% | Form 4, Apr 3, 2023 |
| Regeneron Pharmaceuticals REGN Common Stock | Indirectly (see filing footnote) | 3,609 | $923.34 | $3.3M | 0.8% | Form 4, Apr 3, 2023 |
| Regeneron Pharmaceuticals REGN Common Stock | Through Spouse as Trustee | 1,963 | $923.34 | $1.8M | 0.4% | Form 4, Apr 3, 2023 |
Share counts are the amounts P. Roy Vagelos reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 526 | Randolph Altschuler Director, Xometry. North Bethesda, MD | $433M |
| 527 | Ira Ehrenpreis Director, Tesla. Starbase, TX | $432M |
| 528 | Dean Solon 10% owner, Shoals Technologies Group. Portland, TN | $432M |
| 529 | P. Roy Vagelos Director, Regeneron Pharmaceuticals. Tarrytown, NY | $431M |
| 530 | Jonathan Gray President & COO, Blackstone. New York, NY | $430M |
| 531 | George M. Marcus Director, Marcus & Millichap. San Mateo, CA | $429M |
| 532 | Carl M. Eschenbach Insider, Snowflake. Pleasanton, CA | $428M |
Other Regeneron Pharmaceuticals insiders
All REGN insiders- Leonard S. Schleifer$2.21BBd. Co-Chair, President & CEO. #141 overall
- George Yancopoulos$855MBd. Co-Chair, President & CSO. #312 overall
- Neil E. Stahl$54.7MEVP Research and Development. #2374 overall
- Andrew Murphy$47.3MCo-Chief Scientific Officer. #2647 overall
- Joseph LaRosa$44.4MEVP General Counsel and Secret. #2766 overall
- Daniel P. Van Plew$32.5MEVP & General Mgr, Industrial. #3545 overall
Questions
How much stock does P. Roy Vagelos own?
P. Roy Vagelos holds $431,295,807 in listed stock based on SEC filings and current prices, mostly Regeneron Pharmaceuticals (REGN). That ranks 529th on the Stock Rich List.
Is this P. Roy Vagelos's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.